Literature DB >> 27900094

Malignant transformation of hepatocellular adenoma with bone marrow metaplasia arising in glycogen storage disease type I: A case report.

Tomohiro Iguchi1, Motoyuki Yamagata2, Takashi Sonoda2, Kimihiko Yanagita3, Tetsuhiro Fukahori4, Eiji Tsujita1, Shinichi Aishima5, Yoshinao Oda6, Yoshihiko Maehara7.   

Abstract

Malignant transformation of hepatocellular adenoma (HA) is relatively rare and has been reported to be associated with dysregulation of the β-catenin pathway. The presence of bone marrow metaplasia in HA is an uncommon histological characteristic. The current report presents the case of a 46-year-old woman with glycogen storage disease type I (von Gierke's disease) who underwent resection of hepatocellular carcinoma (HCC) arising in a HA with associated bone marrow metaplasia producing three series of hematopoietic cells. The serum level of proteins induced by des-gamma-carboxy prothrombin (DCP) gradually increased as the tumors grew; following hepatic resection, DCP levels returned to normal. Nuclear accumulation of β-catenin was shown in HCC by immunohistochemistry; however, no mutation was detected in exon 3 of β-catenin. To the best of our knowledge, this is the first report of HA with absolute bone marrow metaplasia producing three series of hematopoietic cells. This occurrence suggests that elevated DCP may be an indicator of malignant transformation of HA.

Entities:  

Keywords:  bone marrow metaplasia; des-gamma-carboxy prothrombin; hepatocellular adenoma; hepatocellular carcinoma; β-catenin

Year:  2016        PMID: 27900094      PMCID: PMC5103882          DOI: 10.3892/mco.2016.1034

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  14 in total

1.  Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma.

Authors:  S C Gordon; K R Reddy; A S Livingstone; L J Jeffers; E R Schiff
Journal:  Ann Intern Med       Date:  1986-10       Impact factor: 25.391

2.  Hepatic progenitor cells in hepatocellular adenomas.

Authors:  L Libbrecht; R De Vos; D Cassiman; V Desmet; R Aerts; T Roskams
Journal:  Am J Surg Pathol       Date:  2001-11       Impact factor: 6.394

3.  Liver-cell adenomas associated with use of oral contraceptives.

Authors:  H A Edmondson; B Henderson; B Benton
Journal:  N Engl J Med       Date:  1976-02-26       Impact factor: 91.245

Review 4.  Management of Hepatocellular Adenoma: Recent Advances.

Authors:  Shefali Agrawal; Sheela Agarwal; Thomas Arnason; Sanjay Saini; Jacques Belghiti
Journal:  Clin Gastroenterol Hepatol       Date:  2014-06-05       Impact factor: 11.382

Review 5.  Management of benign hepatic tumors.

Authors:  Joseph F Buell; Hadrien Tranchart; Robert Cannon; Ibrahim Dagher
Journal:  Surg Clin North Am       Date:  2010-06-08       Impact factor: 2.741

Review 6.  Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma.

Authors:  Sandra Rebouissou; Paulette Bioulac-Sage; Jessica Zucman-Rossi
Journal:  J Hepatol       Date:  2007-10-30       Impact factor: 25.083

7.  Liver cell adenoma with malignant transformation: a case report.

Authors:  Masahiro Ito; Makoto Sasaki; Chun Yang Wen; Masahiro Nakashima; Toshihito Ueki; Hiromi Ishibashi; Michitami Yano; Masayoshi Kage; Masamichi Kojiro
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

Review 8.  Glycogen storage disease I and hepatocellular tumours.

Authors:  L Bianchi
Journal:  Eur J Pediatr       Date:  1993       Impact factor: 3.183

9.  Case report: hepatic adenoma with bone marrow metaplasia in a patient with glycogen storage disease type 1a.

Authors:  S Moriura; M Kuroda; A Kimura; Y Iwatsuka; S Ikeda; T Sakai; A Usui
Journal:  J Gastroenterol Hepatol       Date:  1996-06       Impact factor: 4.029

10.  Giant hepatic adenoma with bone marrow metaplasia not associated with oral contraceptive intake.

Authors:  Giovanni Ramacciato; Giuseppe R Nigri; Paolo Aurello; Francesco D'Angelo; Francesca Pezzoli; Simone Rossi; Emanuela Pilozzi; Giorgio Ercolani; Matteo Ravaioli
Journal:  World J Surg Oncol       Date:  2006-08-25       Impact factor: 2.754

View more
  3 in total

1.  The transcription factor 7 like 2‑binding protein TIP5 activates β‑catenin/transcription factor signaling in hepatocellular carcinoma.

Authors:  Chushi Li; Wei Wu; Hongmei Ding; Qingyang Li; Kangkang Xie
Journal:  Mol Med Rep       Date:  2018-03-28       Impact factor: 2.952

2.  Hepatocellular Carcinoma Arising in a Huge Hepatocellular Adenoma with Bone Marrow Metaplasia.

Authors:  Hyo Jeong Kang; Hui Jeong Jeong; So-Woon Kim; Eunsil Yu; Young-Joo Lee; So Yeon Kim; Jihun Kim
Journal:  J Pathol Transl Med       Date:  2017-12-27

3.  Unclassified hepatocellular adenoma with histological brown pigment deposition and serum PIVKA-II level elevation: a case report.

Authors:  Kouki Hoshino; Norifumi Harimoto; Ryo Muranushi; Kei Hagiwara; Takahiro Yamanaka; Norihiro Ishii; Mariko Tsukagoshi; Takamichi Igarashi; Akira Watanabe; Norio Kubo; Kenichiro Araki; Ran Tomomasa; Sumihito Nobusawa; Shinichi Aishima; Osamu Nakashima; Ken Shirabe
Journal:  Surg Case Rep       Date:  2020-05-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.